Development of a selective agonist for relaxin family peptide receptor 3
Abstract Relaxin family peptides perform a variety of biological functions by activating four G protein-coupled receptors, namely RXFP1–4. Among these receptors, RXFP3 lacks a specific natural or synthetic agonist at present. A previously designed chimeric R3/I5 peptide, consisting of the B-chain of...
Guardado en:
Autores principales: | Dian Wei, Meng-Jun Hu, Xiao-Xia Shao, Jia-Hui Wang, Wei-Han Nie, Ya-Li Liu, Zeng-Guang Xu, Zhan-Yun Guo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd1d78fe5c3a428ab981eb57cc8c7a40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Shoni Bruell, et al.
Publicado: (2017) -
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
por: Martina Kocan, et al.
Publicado: (2017) -
Using paleogenomics to study the evolution of gene families: origin and duplication history of the relaxin family hormones and their receptors.
por: Sergey Yegorov, et al.
Publicado: (2012) -
The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1
por: Ashish Sethi, et al.
Publicado: (2016) -
Nephroprotective potential of glucagon-like peptide-1 receptor agonists
por: Minara S. Shamkhalova, et al.
Publicado: (2020)